Per the package insert, there are no known contraindications to the use of intramuscular polysulfated glycosaminoglycan. Individual horses may vary in their tolerance to any product.
WARNINGS: Do not use in horses intended for human consumption. Not for use in humans. Keep this and all medications out of the reach of children.
PRECAUTIONS: The safe use of Adequan® i.m. in horses used for breeding purposes, during pregnancy, or in lactating mares has not been evaluated.
ANIMAL SAFETY: Toxicity studies were conducted in horses. Doses as high as 2,500 mg were administered intramuscularly to 6 horses twice a week for 12 weeks.
This dosage is 5 times the recommended dosage and 3 times the recommended therapeutic regimen. Clinical observations revealed no soreness or swelling at the
injection site or in the affected joint. No animal had any clinical or laboratory evidence of toxicity.
For full Adequan® i.m. prescribing information, click here .
To view the Safety Data Sheet, click here.
For more frequently asked questions: